Back to companies

Amylyx Pharmaceuticals Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Amylyx Pharmaceuticals Inc (Amylyx) is a clinical-stage pharmaceutical company that develops novel therapies for diseases with high unmet needs. Its products include investigational therapies such as avexitide for post-bariatric hypoglycemia (PBH) congenital hyperinsulinism (HI); AMX0035 for wolfram syndrome and progressive supranuclear palsy (PSP); and AMX0114 for amyotrophic lateral sclerosis (ALS). Amylyx' product candidate focuses on reducing neuronal death by mitigating endoplasmic reticulum stress and mitochondrial dysfunction. The company operates in the US, Canada and the Netherlands. Amylyx is headquartered in Cambridge, Massachusetts, the US.

 Gain a 360-degree view of Amylyx Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Amylyx Pharmaceuticals Inc and make more informed decisions for your business Register your interest
Headquarters United States of America
Address 55 Cambridge Parkway, Suite 6w, Massachusetts, 02142
Website www.amylyx.com
Telephone 1 617 6820917
No of Employees 123
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange AMLX (NASD)
Revenue (2024) $87.4M -77.1% (2024 vs 2023)
EPS XYZ
Net Income (2024) XYZ -712.4% (2024 vs 2023)
Market Cap* $2.0B
Net Profit Margin (2024) XYZ -2,768.9% (2024 vs 2023)
* As of and is in US$
View Amylyx Pharmaceuticals Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Amylyx Pharmaceuticals Inc premium industry data and analytics

50+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Amylyx Pharmaceuticals Inc’s relevant decision makers and contact details.

30+

Catalyst Calendar

Proactively evaluate Amylyx Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

12+

Clinical Trials

Determine Amylyx Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

3

Pipeline Drugs

Identify which of Amylyx Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

2

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Marketed Drugs

Understand Amylyx Pharmaceuticals Inc’s commercialized product portfolio to stay one step ahead of the market.

Products and Services

Products
Pipeline
Avexitide
Post-Bariatric Hypoglycemia (PBH)
XYZ
XYZ
XYZ
Understand Amylyx Pharmaceuticals Inc portfolio and identify potential areas for collaboration Understand Amylyx Pharmaceuticals Inc portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters Amylyx Pharmaceuticals Inc Voyager Therapeutics Inc Pear Therapeutics Inc Aprea Therapeutics Inc
Headquarters United States of America United States of America United States of America United States of America
City Cambridge Lexington Boston Doylestown
State/Province Massachusetts Massachusetts Massachusetts Pennsylvania
No. of Employees 123 172 200 8
Entity Type Public Public Private Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
George Mclean Milne Ph.D. Chairman Executive Board 2015 81
Justin Klee Director; Director - Co Chief Executive Officer Executive Board 2014 34
Joshua Cohen Director; Co Chief Executive Officer Executive Board 2014 33
James M. Frates Chief Financial Officer Senior Management 2021 57
Gina M. Mazzariello Chief Legal Officer; General Counsel Senior Management 2022 53
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Amylyx Pharmaceuticals Inc key executives to enhance your sales strategy Gain insight into Amylyx Pharmaceuticals Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?